Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/1289

TDMS Study 05044-01 Pathology Tables


                                     INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)
                                                  4-VINYL-1-CYCLOHEXENE DIEPOXIDE


NTP Experiment-Test: 05044-01                                                                                     Report: PEIRPT03
Study Type: CHRONIC                                                                                               Date: 09/06/94
Route: DERMAL,SOLUTION                                                                                            Time: 10:15:13




       Facility:  Battelle Columbus Laboratory

       Chemical CAS #:  106-87-6

       Lock Date:  None

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All
































a  Number of animals examined microscopically at site and number of animals with lesion

                                                             Page   1

NTP Experiment-Test: 05044-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  4-VINYL-1-CYCLOHEXENE DIEPOXIDE                              Date: 09/06/94  
Route: DERMAL,SOLUTION                                                                                            Time: 10:15:13  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0 MG/ML      50 MG/ML     100 MG/                                                
                                                                             ML                                                     
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          60           60           60                                                  
  Scheduled Sacrifice                                 10           10           10                                                  
  Early Deaths                                                                                                                      
    Dead                                               8           13           21                                                  
    Moribund                                          15           14           14                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                27           23           15                                                  
  Animals Examined Microscopically                    50           50           50                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Cecum                             (46)         (47)         (45)                                                
      Parasite Metazoan                                             1 (2%)       1 (2%)                                             
   Intestine Large, Colon                             (47)         (50)         (48)                                                
      Inflammation, Suppurative                        1 (2%)                                                                       
      Parasite Metazoan                                             1 (2%)       3 (6%)                                             
   Intestine Large, Rectum                            (48)         (48)         (48)                                                
      Inflammation, Suppurative                        1 (2%)                                                                       
      Parasite Metazoan                                5 (10%)      7 (15%)      4 (8%)                                             
   Intestine Small, Duodenum                          (50)         (49)         (49)                                                
      Inflammation, Acute, Necrotizing                 1 (2%)                                                                       
   Intestine Small, Ileum                             (47)         (44)         (42)                                                
      Inflammation, Acute, Necrotizing                                           1 (2%)                                             
   Liver                                              (50)         (50)         (50)                                                
      Angiectasis                                                                1 (2%)                                             
      Basophilic Focus                                38 (76%)     32 (64%)     35 (70%)                                            
      Clear Cell Focus                                              2 (4%)                                                          
      Degeneration, Cystic                                          1 (2%)                                                          
      Eosinophilic Focus                                            1 (2%)                                                          
      Fatty Change                                     9 (18%)      5 (10%)      1 (2%)                                             
      Hepatodiaphragmatic Nodule                       3 (6%)       2 (4%)       3 (6%)                                             
      Hyperplasia, Focal                                            1 (2%)                                                          
      Inflammation, Acute, Necrotizing                 1 (2%)       1 (2%)       2 (4%)                                             
      Inflammation, Chronic Active                                  4 (8%)       2 (4%)                                             
      Bile Duct, Hyperplasia                           7 (14%)     10 (20%)     14 (28%)                                            
      Centrilobular, Necrosis                          5 (10%)      5 (10%)      1 (2%)                                             
      Hepatocyte, Regeneration                         1 (2%)                                                                       
   Mesentery                                          (4)          (2)                                                              
      Inflammation, Acute, Necrotizing                 1 (25%)                                                                      
      Inflammation, Chronic Active                     3 (75%)                                                                      
      Artery, Inflammation, Chronic Active                          1 (50%)                                                         
   Pancreas                                           (48)         (47)         (48)                                                
      Focal Cellular Change                                         1 (2%)                                                          
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    2                                                              
NTP Experiment-Test: 05044-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  4-VINYL-1-CYCLOHEXENE DIEPOXIDE                              Date: 09/06/94  
Route: DERMAL,SOLUTION                                                                                            Time: 10:15:13  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0 MG/ML      50 MG/ML     100 MG/                                                
                                                                             ML                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Inflammation, Acute                                                        1 (2%)                                             
      Inflammation, Chronic Active                     2 (4%)       1 (2%)                                                          
      Metaplasia                                       1 (2%)                                                                       
      Acinus, Atrophy                                 19 (40%)     17 (36%)     17 (35%)                                            
      Acinus, Hyperplasia                              1 (2%)                                                                       
   Pharynx                                                         (1)          (1)                                                 
      Inflammation, Suppurative                                                  1 (100%)                                           
   Salivary Glands                                    (50)         (50)         (50)                                                
      Atrophy                                          1 (2%)                    1 (2%)                                             
      Focal Cellular Change                                         1 (2%)                                                          
      Inflammation, Suppurative                        1 (2%)                                                                       
      Necrosis                                         1 (2%)                                                                       
      Duct, Inflammation, Chronic Active                                         1 (2%)                                             
   Stomach, Forestomach                               (50)         (48)         (50)                                                
      Inflammation, Chronic Active                     2 (4%)       3 (6%)                                                          
      Ulcer                                            5 (10%)                                                                      
      Epithelium, Hyperplasia                          5 (10%)      4 (8%)                                                          
   Stomach, Glandular                                 (50)         (48)         (50)                                                
      Inflammation, Acute, Necrotizing                 4 (8%)       2 (4%)       1 (2%)                                             
      Inflammation, Chronic Active                     2 (4%)                                                                       
      Mineralization                                   1 (2%)                                                                       
   Tooth                                              (2)          (1)          (2)                                                 
      Dysplasia                                        1 (50%)                                                                      
      Gingiva, Hyperplasia, Squamous                                             1 (50%)                                            
      Peridontal Tissue, Inflammation, Suppurative     1 (50%)      1 (100%)     1 (50%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (50)         (50)                                                
      Degeneration, Chronic                           45 (90%)     40 (80%)     35 (70%)                                            
      Inflammation, Suppurative                        1 (2%)                                                                       
      Mineralization                                   1 (2%)                                                                       
      Atrium, Thrombosis                               2 (4%)       1 (2%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (50)         (48)         (50)                                                
      Hyperplasia                                     38 (76%)     29 (60%)     34 (68%)                                            
      Hypertrophy                                      4 (8%)       1 (2%)       2 (4%)                                             
      Necrosis                                         1 (2%)                    1 (2%)                                             
      Vacuolization Cytoplasmic                        1 (2%)       1 (2%)       1 (2%)                                             
   Adrenal Gland, Medulla                             (50)         (48)         (50)                                                
      Hyperplasia                                      9 (18%)     10 (21%)      6 (12%)                                            
   Islets, Pancreatic                                 (48)         (48)         (48)                                                
      Hyperplasia                                      2 (4%)                                                                       
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    3                                                              
NTP Experiment-Test: 05044-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  4-VINYL-1-CYCLOHEXENE DIEPOXIDE                              Date: 09/06/94  
Route: DERMAL,SOLUTION                                                                                            Time: 10:15:13  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0 MG/ML      50 MG/ML     100 MG/                                                
                                                                             ML                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
   Parathyroid Gland                                  (47)         (43)         (48)                                                
      Hyperplasia                                      1 (2%)                                                                       
   Pituitary Gland                                    (47)         (49)         (48)                                                
      Cyst                                             1 (2%)                                                                       
      Pars Distalis, Degeneration, Focal                                         1 (2%)                                             
      Pars Distalis, Hyperplasia                      19 (40%)     20 (41%)     15 (31%)                                            
   Thyroid Gland                                      (46)         (48)         (49)                                                
      Inflammation, Chronic Active                     1 (2%)       1 (2%)                                                          
      C-Cell, Hyperplasia                             37 (80%)     33 (69%)     23 (47%)                                            
      Follicular Cell, Hyperplasia                     2 (4%)       2 (4%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (45)         (50)         (49)                                                
      Hyperplasia                                      6 (13%)      3 (6%)       4 (8%)                                             
      Inflammation, Acute, Necrotizing                              1 (2%)       2 (4%)                                             
      Inflammation, Chronic Active                     8 (18%)      2 (4%)       5 (10%)                                            
      Duct, Hyperplasia                                             1 (2%)       2 (4%)                                             
   Ovary                                              (50)         (49)         (50)                                                
      Cyst                                             4 (8%)       5 (10%)      9 (18%)                                            
   Uterus                                             (50)         (50)         (50)                                                
      Dilatation                                                    1 (2%)                                                          
      Inflammation, Chronic Active                                  2 (4%)                                                          
      Prolapse                                                      1 (2%)       1 (2%)                                             
   Vagina                                             (3)                                                                           
      Inflammation, Suppurative                        3 (100%)                                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (49)         (49)                                                
      Femoral, Hyperplasia, Reticulum Cell             4 (8%)       5 (10%)      6 (12%)                                            
      Femoral, Myelofibrosis                           3 (6%)       1 (2%)                                                          
      Femoral, Necrosis                                1 (2%)                    1 (2%)                                             
      Femoral, Myeloid Cell, Hyperplasia                                         1 (2%)                                             
   Lymph Node                                         (50)         (50)         (50)                                                
      Mediastinal, Hematopoietic Cell Proliferation                              1 (2%)                                             
   Lymph Node, Mandibular                             (50)         (50)         (50)                                                
      Hematopoietic Cell Proliferation                                           1 (2%)                                             
      Inflammation, Acute, Necrotizing                              1 (2%)                                                          
   Lymph Node, Mesenteric                             (3)                       (2)                                                 
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    4                                                              
NTP Experiment-Test: 05044-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  4-VINYL-1-CYCLOHEXENE DIEPOXIDE                              Date: 09/06/94  
Route: DERMAL,SOLUTION                                                                                            Time: 10:15:13  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0 MG/ML      50 MG/ML     100 MG/                                                
                                                                             ML                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Edema                                            1 (33%)                   1 (50%)                                            
   Spleen                                             (50)         (50)         (49)                                                
      Fibrosis                                         2 (4%)       2 (4%)       1 (2%)                                             
      Hematopoietic Cell Proliferation                                           3 (6%)                                             
      Hemorrhage, Chronic                                                        1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (50)         (49)         (50)                                                
      Hyperplasia, Cystic                             41 (82%)     20 (41%)     37 (74%)                                            
   Skin                                               (50)         (50)         (50)                                                
      Inflammation, Acute, Necrotizing                 1 (2%)                                                                       
      Inflammation, Chronic Active                                               1 (2%)                                             
      Back, Acanthosis                                 1 (2%)       4 (8%)      11 (22%)                                            
      Back, Sebaceous Gland, Hypertrophy                                        15 (30%)                                            
      Hair Follicle, Inflammation, Chronic             1 (2%)                                                                       
      Scapula, Acanthosis                              4 (8%)      33 (66%)     42 (84%)                                            
      Scapula, Cyst Epithelial Inclusion                            1 (2%)                                                          
      Scapula, Inflammation, Acute, Necrotizing        1 (2%)       1 (2%)       1 (2%)                                             
      Scapula, Inflammation, Chronic Active                         1 (2%)                                                          
      Sebaceous Gland, Scapula, Hypertrophy            1 (2%)      20 (40%)     43 (86%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)                                                
      Cranium, Fibrous Osteodystrophy                  1 (2%)                                                                       
      Femur, Fibrous Osteodystrophy                    1 (2%)                                                                       
      Mandible, Fibrous Osteodystrophy                 1 (2%)                                                                       
      Tarsal, Hyperostosis                             1 (2%)                                                                       
      Tarsal, Inflammation, Chronic Active             1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)                                                
      Compression                                     12 (24%)      7 (14%)      5 (10%)                                            
      Infarct                                          1 (2%)                    1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)                                                
      Inflammation, Chronic Active                     4 (8%)       4 (8%)       6 (12%)                                            
      Mineralization                                   1 (2%)                                                                       
      Alveolar Epithelium, Hyperplasia                              2 (4%)                                                          
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    5                                                              
NTP Experiment-Test: 05044-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  4-VINYL-1-CYCLOHEXENE DIEPOXIDE                              Date: 09/06/94  
Route: DERMAL,SOLUTION                                                                                            Time: 10:15:13  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS FEMALE                   0 MG/ML      50 MG/ML     100 MG/                                                
                                                                             ML                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
      Mediastinum, Inflammation, Chronic Active                                  1 (2%)                                             
   Nose                                               (49)         (50)         (49)                                                
      Hyperplasia, Squamous                                                      1 (2%)                                             
      Mucosa, Inflammation, Suppurative                             2 (4%)       3 (6%)                                             
      Mucosa, Thrombosis                               2 (4%)                                                                       
      Nasolacrimal Duct, Inflammation, Suppurative     2 (4%)       2 (4%)       3 (6%)                                             
   Trachea                                            (50)         (50)         (49)                                                
      Inflammation, Chronic Active                                               1 (2%)                                             
      Metaplasia, Squamous                                                       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (5)          (3)          (3)                                                 
      Degeneration                                     4 (80%)      2 (67%)      2 (67%)                                            
   Harderian Gland                                                              (2)                                                 
      Inflammation, Chronic                                                      2 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (49)                                                
      Amyloid Deposition                                            1 (2%)                                                          
      Bacterium                                        1 (2%)                                                                       
      Inflammation, Suppurative                        1 (2%)                                                                       
      Mineralization                                   1 (2%)                                                                       
      Nephropathy, Chronic                            47 (94%)     45 (90%)     46 (94%)                                            
      Cortex, Atrophy, Focal                                        1 (2%)                                                          
      Pelvis, Inflammation, Suppurative                             1 (2%)                                                          
      Renal Tubule, Hyperplasia                        6 (12%)                                                                      
   Urinary Bladder                                    (50)         (50)         (48)                                                
      Transitional Epithelium, Hyperplasia                          1 (2%)       1 (2%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    6                                                              
NTP Experiment-Test: 05044-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  4-VINYL-1-CYCLOHEXENE DIEPOXIDE                              Date: 09/06/94  
Route: DERMAL,SOLUTION                                                                                            Time: 10:15:13  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 MG/ML      50 MG/ML     100 MG/                                                
                                                                             ML                                                     
____________________________________________________________________________________________________________________________________
DISPOSITION SUMMARY                                                                                                                 
  Animals Initially In Study                          60           60           60                                                  
  Scheduled Sacrifice                                 10           10           10                                                  
  Early Deaths                                                                                                                      
    Moribund                                          31           37           29                                                  
    Dead                                              12            5           16                                                  
    Drowned                                                                      1                                                  
  Survivors                                                                                                                         
    Terminal Sacrifice                                 7            8            4                                                  
  Animals Examined Microscopically                    50           50           50                                                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (50)         (50)         (49)                                                
      Inflammation, Acute, Necrotizing                                           1 (2%)                                             
   Intestine Large, Cecum                             (45)         (48)         (40)                                                
      Inflammation, Suppurative                        1 (2%)                    1 (3%)                                             
      Parasite Metazoan                                1 (2%)       1 (2%)       1 (3%)                                             
      Thrombosis                                       1 (2%)                                                                       
   Intestine Large, Colon                             (48)         (49)         (40)                                                
      Mineralization                                   5 (10%)      3 (6%)                                                          
      Parasite Metazoan                                2 (4%)       2 (4%)                                                          
   Intestine Large, Rectum                            (48)         (48)         (44)                                                
      Inflammation, Suppurative                        1 (2%)                                                                       
      Mineralization                                   2 (4%)       2 (4%)                                                          
      Parasite Metazoan                                4 (8%)                    1 (2%)                                             
   Intestine Small, Duodenum                          (48)         (50)         (45)                                                
      Inflammation, Acute, Necrotizing                 4 (8%)       5 (10%)      1 (2%)                                             
      Mineralization                                                1 (2%)                                                          
      Thrombosis                                       1 (2%)                                                                       
   Intestine Small, Ileum                             (44)         (49)         (37)                                                
      Inflammation, Acute, Necrotizing                 1 (2%)       1 (2%)                                                          
   Liver                                              (50)         (50)         (50)                                                
      Basophilic Focus                                15 (30%)     15 (30%)     10 (20%)                                            
      Degeneration, Cystic                             7 (14%)      7 (14%)      3 (6%)                                             
      Eosinophilic Focus                                            1 (2%)                                                          
      Fatty Change                                     5 (10%)      6 (12%)      2 (4%)                                             
      Hepatodiaphragmatic Nodule                       1 (2%)       1 (2%)       1 (2%)                                             
      Inflammation, Acute, Necrotizing                              3 (6%)       2 (4%)                                             
      Inflammation, Chronic Active                     1 (2%)                                                                       
      Thrombosis                                                    1 (2%)                                                          
      Bile Duct, Cyst                                                            1 (2%)                                             
      Bile Duct, Hyperplasia                          20 (40%)     39 (78%)     19 (38%)                                            
      Centrilobular, Necrosis                         11 (22%)      9 (18%)      8 (16%)                                            
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    7                                                              
NTP Experiment-Test: 05044-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  4-VINYL-1-CYCLOHEXENE DIEPOXIDE                              Date: 09/06/94  
Route: DERMAL,SOLUTION                                                                                            Time: 10:15:13  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 MG/ML      50 MG/ML     100 MG/                                                
                                                                             ML                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Hepatocyte, Regeneration                                      1 (2%)                                                          
   Mesentery                                          (7)          (6)          (6)                                                 
      Inflammation, Acute, Necrotizing                 1 (14%)                   2 (33%)                                            
      Inflammation, Chronic Active                     2 (29%)                   1 (17%)                                            
      Artery, Mineralization                           4 (57%)      3 (50%)      1 (17%)                                            
   Pancreas                                           (50)         (50)         (45)                                                
      Inflammation, Acute                                                        1 (2%)                                             
      Inflammation, Chronic Active                     1 (2%)                    1 (2%)                                             
      Acinus, Atrophy                                 23 (46%)     24 (48%)     19 (42%)                                            
      Acinus, Hyperplasia                              2 (4%)                    1 (2%)                                             
      Artery, Mineralization                           1 (2%)                                                                       
   Pharynx                                            (2)          (2)                                                              
      Inflammation, Suppurative                        1 (50%)      2 (100%)                                                        
   Salivary Glands                                    (50)         (50)         (50)                                                
      Inflammation, Suppurative                        1 (2%)                                                                       
      Necrosis                                                      1 (2%)                                                          
      Artery, Mineralization                           2 (4%)                                                                       
   Stomach, Forestomach                               (50)         (50)         (47)                                                
      Inflammation, Chronic Active                     1 (2%)      10 (20%)      2 (4%)                                             
      Mineralization                                   6 (12%)      3 (6%)       1 (2%)                                             
      Ulcer                                            8 (16%)      6 (12%)      8 (17%)                                            
      Epithelium, Hyperplasia                          6 (12%)     10 (20%)      2 (4%)                                             
   Stomach, Glandular                                 (50)         (50)         (48)                                                
      Inflammation, Acute, Necrotizing                11 (22%)      3 (6%)       5 (10%)                                            
      Mineralization                                  10 (20%)     11 (22%)      4 (8%)                                             
   Tooth                                              (2)          (5)                                                              
      Dysplasia                                                     1 (20%)                                                         
      Peridontal Tissue, Inflammation, Suppurative     2 (100%)     4 (80%)                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (7)          (5)          (2)                                                 
      Aneurysm                                                      1 (20%)                                                         
      Aorta, Mineralization                            7 (100%)     4 (80%)      2 (100%)                                           
   Heart                                              (50)         (50)         (50)                                                
      Degeneration, Chronic                           45 (90%)     42 (84%)     48 (96%)                                            
      Inflammation, Suppurative                                     2 (4%)       3 (6%)                                             
      Mineralization                                   9 (18%)      7 (14%)      3 (6%)                                             
      Atrium, Thrombosis                               4 (8%)       3 (6%)       2 (4%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    8                                                              
NTP Experiment-Test: 05044-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  4-VINYL-1-CYCLOHEXENE DIEPOXIDE                              Date: 09/06/94  
Route: DERMAL,SOLUTION                                                                                            Time: 10:15:13  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 MG/ML      50 MG/ML     100 MG/                                                
                                                                             ML                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Gland, Cortex                              (50)         (50)         (50)                                                
      Hyperplasia                                     23 (46%)     24 (48%)     31 (62%)                                            
      Hypertrophy                                      1 (2%)                                                                       
      Necrosis                                                      3 (6%)       2 (4%)                                             
      Vacuolization Cytoplasmic                                     1 (2%)                                                          
   Adrenal Gland, Medulla                             (50)         (50)         (50)                                                
      Hyperplasia                                     28 (56%)     28 (56%)     20 (40%)                                            
   Islets, Pancreatic                                 (50)         (50)         (46)                                                
      Hyperplasia                                      2 (4%)       1 (2%)       5 (11%)                                            
   Parathyroid Gland                                  (49)         (45)         (45)                                                
      Hyperplasia                                     14 (29%)     14 (31%)      4 (9%)                                             
      Hypertrophy                                                   1 (2%)                                                          
   Pituitary Gland                                    (50)         (50)         (48)                                                
      Pars Distalis, Cyst                              1 (2%)                                                                       
      Pars Distalis, Hyperplasia                      23 (46%)     10 (20%)     11 (23%)                                            
      Pars Distalis, Mineralization                    2 (4%)       1 (2%)                                                          
      Pars Distalis, Necrosis                                       1 (2%)                                                          
   Thyroid Gland                                      (48)         (50)         (43)                                                
      Mineralization                                   1 (2%)       1 (2%)                                                          
      Pigmentation, Lipofuscin                                      1 (2%)                                                          
      C-Cell, Hyperplasia                             28 (58%)     30 (60%)     22 (51%)                                            
      Follicular Cell, Hyperplasia                                  2 (4%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Ductus Deferens                                    (2)                       (1)                                                 
      Mineralization                                   2 (100%)                  1 (100%)                                           
   Epididymis                                         (50)         (50)         (48)                                                
      Mineralization                                                             1 (2%)                                             
   Penis                                                                        (1)                                                 
      Inflammation, Acute, Necrotizing                                           1 (100%)                                           
   Preputial Gland                                    (49)         (49)         (50)                                                
      Hyperplasia                                      1 (2%)                    3 (6%)                                             
      Inflammation, Chronic Active                    11 (22%)     16 (33%)      9 (18%)                                            
      Duct, Hyperplasia                                             1 (2%)       1 (2%)                                             
   Prostate                                           (49)         (50)         (50)                                                
      Inflammation, Chronic Active                    34 (69%)     32 (64%)     41 (82%)                                            
      Epithelium, Hyperplasia                                                    1 (2%)                                             
   Testes                                             (50)         (50)         (50)                                                
      Cyst                                                          1 (2%)                                                          
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page    9                                                              
NTP Experiment-Test: 05044-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  4-VINYL-1-CYCLOHEXENE DIEPOXIDE                              Date: 09/06/94  
Route: DERMAL,SOLUTION                                                                                            Time: 10:15:13  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 MG/ML      50 MG/ML     100 MG/                                                
                                                                             ML                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
      Thrombosis                                       1 (2%)                                                                       
      Interstitial Cell, Hyperplasia                   9 (18%)      7 (14%)     14 (28%)                                            
      Seminiferous Tubule, Atrophy                     9 (18%)      2 (4%)       4 (8%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (49)                                                
      Femoral, Myelofibrosis                           3 (6%)       1 (2%)       4 (8%)                                             
   Lymph Node, Mandibular                             (50)         (49)         (50)                                                
      Edema                                                                      2 (4%)                                             
      Inflammation, Acute, Necrotizing                              1 (2%)                                                          
   Lymph Node, Mesenteric                             (7)          (10)         (3)                                                 
      Edema                                            1 (14%)      4 (40%)                                                         
      Hemorrhage                                                    1 (10%)                                                         
      Inflammation, Acute, Necrotizing                              1 (10%)                                                         
   Spleen                                             (50)         (50)         (49)                                                
      Abscess                                                                    1 (2%)                                             
      Amyloid Deposition                                                         1 (2%)                                             
      Fibrosis                                         8 (16%)      8 (16%)      7 (14%)                                            
      Hematopoietic Cell Proliferation                 1 (2%)       1 (2%)       1 (2%)                                             
      Hemorrhage, Chronic                                           1 (2%)                                                          
      Necrosis                                                      3 (6%)       3 (6%)                                             
   Thymus                                             (41)         (40)         (42)                                                
      Cyst                                             1 (2%)                                                                       
      Inflammation, Acute, Necrotizing                              1 (3%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (45)         (48)         (42)                                                
      Hyperplasia, Cystic                             34 (76%)     25 (52%)     36 (86%)                                            
      Mineralization                                   1 (2%)                                                                       
   Skin                                               (50)         (50)         (50)                                                
      Abscess                                          2 (4%)                                                                       
      Acanthosis                                                    2 (4%)       1 (2%)                                             
      Cyst Epithelial Inclusion, Multiple                                        1 (2%)                                             
      Inflammation, Acute, Necrotizing                 3 (6%)       1 (2%)       2 (4%)                                             
      Mineralization                                   1 (2%)                                                                       
      Back, Acanthosis                                              6 (12%)      8 (16%)                                            
      Back, Inflammation, Acute, Necrotizing                        1 (2%)                                                          
      Back, Sebaceous Gland, Hypertrophy                            4 (8%)       8 (16%)                                            
      Scapula, Acanthosis                                          39 (78%)     40 (80%)                                            
      Scapula, Cyst Epithelial Inclusion                            1 (2%)       1 (2%)                                             
      Scapula, Hypertrophy                                          2 (4%)                                                          
      Scapula, Inflammation, Acute, Necrotizing        1 (2%)                    1 (2%)                                             
      Sebaceous Gland, Hypertrophy                                  1 (2%)       1 (2%)                                             
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   10                                                              
NTP Experiment-Test: 05044-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  4-VINYL-1-CYCLOHEXENE DIEPOXIDE                              Date: 09/06/94  
Route: DERMAL,SOLUTION                                                                                            Time: 10:15:13  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 MG/ML      50 MG/ML     100 MG/                                                
                                                                             ML                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
INTEGUMENTARY SYSTEM - CONT                                                                                                         
      Sebaceous Gland, Scapula, Hypertrophy                        28 (56%)     39 (78%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)                                                
      Cranium, Fibrous Osteodystrophy                 13 (26%)     12 (24%)      4 (8%)                                             
      Femur, Fibrous Osteodystrophy                   13 (26%)     12 (24%)      4 (8%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (49)                                                
      Compression                                      7 (14%)      7 (14%)     11 (22%)                                            
      Infarct                                          4 (8%)       2 (4%)       3 (6%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)                                                
      Infarct                                                       1 (2%)       1 (2%)                                             
      Inflammation, Chronic Active                    11 (22%)     15 (30%)      1 (2%)                                             
      Mineralization                                   9 (18%)      7 (14%)      2 (4%)                                             
      Thrombosis                                       1 (2%)                    1 (2%)                                             
      Alveolar Epithelium, Hyperplasia                              3 (6%)                                                          
      Artery, Mediastinum, Mineralization              3 (6%)       6 (12%)                                                         
      Mediastinum, Inflammation, Chronic Active                     1 (2%)                                                          
      Pleura, Inflammation, Suppurative                                          2 (4%)                                             
   Nose                                               (50)         (50)         (49)                                                
      Mucosa, Inflammation, Suppurative               21 (42%)     12 (24%)     13 (27%)                                            
      Mucosa, Thrombosis                               1 (2%)       1 (2%)       3 (6%)                                             
      Nasolacrimal Duct, Inflammation, Suppurative     3 (6%)       2 (4%)       4 (8%)                                             
      Septum, Necrosis                                 1 (2%)                    1 (2%)                                             
   Trachea                                            (50)         (49)         (48)                                                
      Inflammation, Chronic Active                                  1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (7)          (3)          (6)                                                 
      Degeneration                                     3 (43%)      2 (67%)      6 (100%)                                           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   11                                                              
NTP Experiment-Test: 05044-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                  4-VINYL-1-CYCLOHEXENE DIEPOXIDE                              Date: 09/06/94  
Route: DERMAL,SOLUTION                                                                                            Time: 10:15:13  
____________________________________________________________________________________________________________________________________
         FISCHER 344 RATS MALE                     0 MG/ML      50 MG/ML     100 MG/                                                
                                                                             ML                                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (49)                                                
      Hydronephrosis                                                1 (2%)                                                          
      Mineralization                                   9 (18%)      7 (14%)      5 (10%)                                            
      Nephropathy, Chronic                            50 (100%)    49 (98%)     49 (100%)                                           
      Pelvis, Inflammation, Suppurative                2 (4%)       5 (10%)      4 (8%)                                             
      Renal Tubule, Cytoplasmic Alteration             2 (4%)                                                                       
      Renal Tubule, Hyperplasia                        2 (4%)       6 (12%)      4 (8%)                                             
      Renal Tubule, Necrosis                           1 (2%)                                                                       
   Urethra                                            (1)                                                                           
      Inflammation, Suppurative                        1 (100%)                                                                     
   Urinary Bladder                                    (49)         (50)         (49)                                                
      Hemorrhage                                       1 (2%)       1 (2%)                                                          
      Inflammation, Suppurative                        2 (4%)                                                                       
      Mineralization                                   2 (4%)                                                                       
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                             Page   12                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------                                           

--multipart-boundary
Content-type: text/plain
Range: bytes 78027-78027/78027


--multipart-boundary--